DeuterOncology closes financing round to start lung cancer study
DeuterOncology, a clinical-stage drug development company, has closed €5.65 million ($6.1 million) series A financing,…
January 20, 2023 - 2 minutes
lung cancer
EverImmune launches trial for oncobiotic lung and kidney cancer drug candidate
EverImmune, a clinical-stage biotechnology company specialized in the development of live biotherapeutic products in the…
January 17, 2023 - 3 minutes
OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023
Ofer Sharon is the CEO of OncoHost, a biotech company in the precision oncology space.…
December 14, 2022 - 7 minutes
PDC*line Pharma presents first immunological results from trial with PDC*lung01
PDC*line Pharma, a clinical stage biotech company has announced the first immunological results of its…
December 8, 2022 - 3 minutes
Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
Legend Biotech small cell lung cancer drug gets FDA ok for clinical development
Legend Biotech Corporation has announced that the U.S. Food and Drug Administration (FDA) has cleared…
November 21, 2022 - 2 minutes
Immutep announces efti clinical results for non-small cell lung cancer
Immutep Limited has revealed what it says are compelling new clinical data from its TACTI-002…
November 16, 2022 - 3 minutes
New approaches beckon for small cell lung cancer treatment
Small cell lung cancer (SCLC) is a particularly aggressive tumor that has so far been…
October 6, 2022 - 3 minutes
FDA fast tracks Immutep non-small cell lung cancer candidate
Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track…
October 5, 2022 - 3 minutes
Himalaya Therapeutics publishes data on cancer treatment
Himalaya Therapeutics has given an interim topline data update from its phase 2 study of…
September 13, 2022 - 3 minutes
PDC*line Pharma presents results from phase I/II trial
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable…
September 12, 2022 - 3 minutes
Alpha Biopharma announces completion of phase 2/3 clinical study for drug to treat lung cancer
Patients with advanced EGFRm+ non-small cell lung cancer (NSCLC) with central nervous system (CNS) metastases…
August 25, 2022 - 3 minutes
